Psychiatric brain banking: Three perspectives on current trends and future directions

Amy Deep-Soboslay, Francine M. Benes, Vahram Haroutunian, Justin K. Ellis, Joel Kleinman, Thomas Hyde

Research output: Contribution to journalReview article

Abstract

Postmortem human brain tissue is critical for advancing neurobiological studies of psychiatric illness, particularly for identifying brain-specific transcripts and isoforms. State-of-the-art methods and recommendations for maintaining psychiatric brain banks are discussed in three disparate collections, the National Institute of Mental Health Brain Tissue Collection, the Harvard Brain Tissue Resource Center, and the Mount Sinai School of Medicine Alzheimer's Disease and Schizophrenia Brain Bank. While the National Institute of Mental Health Brain Tissue Collection obtains donations from medical examiners and focuses on clinical diagnosis, toxicology, and building life span control cohorts, the Harvard Brain Tissue Resource Center is designed as a repository to collect large-volume, high-quality brain tissue from community-based donors across a nationwide network, placing emphasis on the accessibility of tissue and related data to research groups worldwide. The Mount Sinai School of Medicine Alzheimer's Disease and Schizophrenia Brain Bank has shown that prospective recruitment is a successful approach to tissue donation, placing particular emphasis on clinical diagnosis through antemortem contact with donors, as well as stereological tissue sampling methods for neuroanatomical studies and frozen tissue sampling approaches that enable multiple assessments (e.g., RNA, DNA, protein, enzyme activity, binding) of the same tissue block. Promising scientific approaches for elucidating the molecular and cellular pathways in brain that may contribute to schizophrenia are briefly discussed. Despite different perspectives from three established brain collections, there is consensus that varied networking strategies, rigorous tissue and clinical characterization, sample and data accessibility, and overall adaptability are integral to the success of psychiatric brain banking.

Original languageEnglish (US)
Pages (from-to)104-112
Number of pages9
JournalBiological Psychiatry
Volume69
Issue number2
DOIs
StatePublished - Jan 15 2011
Externally publishedYes

Fingerprint

Psychiatry
Brain
National Institute of Mental Health (U.S.)
Schizophrenia
Direction compound
Alzheimer Disease
Medicine
Tissue Donors
Coroners and Medical Examiners
Tissue and Organ Procurement
Toxicology
Consensus
Protein Isoforms
RNA

Keywords

  • Brain banks
  • brain collections
  • postmortem human brain
  • psychiatric
  • psychosis
  • schizophrenia

ASJC Scopus subject areas

  • Biological Psychiatry

Cite this

Psychiatric brain banking : Three perspectives on current trends and future directions. / Deep-Soboslay, Amy; Benes, Francine M.; Haroutunian, Vahram; Ellis, Justin K.; Kleinman, Joel; Hyde, Thomas.

In: Biological Psychiatry, Vol. 69, No. 2, 15.01.2011, p. 104-112.

Research output: Contribution to journalReview article

Deep-Soboslay, Amy ; Benes, Francine M. ; Haroutunian, Vahram ; Ellis, Justin K. ; Kleinman, Joel ; Hyde, Thomas. / Psychiatric brain banking : Three perspectives on current trends and future directions. In: Biological Psychiatry. 2011 ; Vol. 69, No. 2. pp. 104-112.
@article{129723866cd34dba8391b5abcee5de3f,
title = "Psychiatric brain banking: Three perspectives on current trends and future directions",
abstract = "Postmortem human brain tissue is critical for advancing neurobiological studies of psychiatric illness, particularly for identifying brain-specific transcripts and isoforms. State-of-the-art methods and recommendations for maintaining psychiatric brain banks are discussed in three disparate collections, the National Institute of Mental Health Brain Tissue Collection, the Harvard Brain Tissue Resource Center, and the Mount Sinai School of Medicine Alzheimer's Disease and Schizophrenia Brain Bank. While the National Institute of Mental Health Brain Tissue Collection obtains donations from medical examiners and focuses on clinical diagnosis, toxicology, and building life span control cohorts, the Harvard Brain Tissue Resource Center is designed as a repository to collect large-volume, high-quality brain tissue from community-based donors across a nationwide network, placing emphasis on the accessibility of tissue and related data to research groups worldwide. The Mount Sinai School of Medicine Alzheimer's Disease and Schizophrenia Brain Bank has shown that prospective recruitment is a successful approach to tissue donation, placing particular emphasis on clinical diagnosis through antemortem contact with donors, as well as stereological tissue sampling methods for neuroanatomical studies and frozen tissue sampling approaches that enable multiple assessments (e.g., RNA, DNA, protein, enzyme activity, binding) of the same tissue block. Promising scientific approaches for elucidating the molecular and cellular pathways in brain that may contribute to schizophrenia are briefly discussed. Despite different perspectives from three established brain collections, there is consensus that varied networking strategies, rigorous tissue and clinical characterization, sample and data accessibility, and overall adaptability are integral to the success of psychiatric brain banking.",
keywords = "Brain banks, brain collections, postmortem human brain, psychiatric, psychosis, schizophrenia",
author = "Amy Deep-Soboslay and Benes, {Francine M.} and Vahram Haroutunian and Ellis, {Justin K.} and Joel Kleinman and Thomas Hyde",
year = "2011",
month = "1",
day = "15",
doi = "10.1016/j.biopsych.2010.05.025",
language = "English (US)",
volume = "69",
pages = "104--112",
journal = "Biological Psychiatry",
issn = "0006-3223",
publisher = "Elsevier USA",
number = "2",

}

TY - JOUR

T1 - Psychiatric brain banking

T2 - Three perspectives on current trends and future directions

AU - Deep-Soboslay, Amy

AU - Benes, Francine M.

AU - Haroutunian, Vahram

AU - Ellis, Justin K.

AU - Kleinman, Joel

AU - Hyde, Thomas

PY - 2011/1/15

Y1 - 2011/1/15

N2 - Postmortem human brain tissue is critical for advancing neurobiological studies of psychiatric illness, particularly for identifying brain-specific transcripts and isoforms. State-of-the-art methods and recommendations for maintaining psychiatric brain banks are discussed in three disparate collections, the National Institute of Mental Health Brain Tissue Collection, the Harvard Brain Tissue Resource Center, and the Mount Sinai School of Medicine Alzheimer's Disease and Schizophrenia Brain Bank. While the National Institute of Mental Health Brain Tissue Collection obtains donations from medical examiners and focuses on clinical diagnosis, toxicology, and building life span control cohorts, the Harvard Brain Tissue Resource Center is designed as a repository to collect large-volume, high-quality brain tissue from community-based donors across a nationwide network, placing emphasis on the accessibility of tissue and related data to research groups worldwide. The Mount Sinai School of Medicine Alzheimer's Disease and Schizophrenia Brain Bank has shown that prospective recruitment is a successful approach to tissue donation, placing particular emphasis on clinical diagnosis through antemortem contact with donors, as well as stereological tissue sampling methods for neuroanatomical studies and frozen tissue sampling approaches that enable multiple assessments (e.g., RNA, DNA, protein, enzyme activity, binding) of the same tissue block. Promising scientific approaches for elucidating the molecular and cellular pathways in brain that may contribute to schizophrenia are briefly discussed. Despite different perspectives from three established brain collections, there is consensus that varied networking strategies, rigorous tissue and clinical characterization, sample and data accessibility, and overall adaptability are integral to the success of psychiatric brain banking.

AB - Postmortem human brain tissue is critical for advancing neurobiological studies of psychiatric illness, particularly for identifying brain-specific transcripts and isoforms. State-of-the-art methods and recommendations for maintaining psychiatric brain banks are discussed in three disparate collections, the National Institute of Mental Health Brain Tissue Collection, the Harvard Brain Tissue Resource Center, and the Mount Sinai School of Medicine Alzheimer's Disease and Schizophrenia Brain Bank. While the National Institute of Mental Health Brain Tissue Collection obtains donations from medical examiners and focuses on clinical diagnosis, toxicology, and building life span control cohorts, the Harvard Brain Tissue Resource Center is designed as a repository to collect large-volume, high-quality brain tissue from community-based donors across a nationwide network, placing emphasis on the accessibility of tissue and related data to research groups worldwide. The Mount Sinai School of Medicine Alzheimer's Disease and Schizophrenia Brain Bank has shown that prospective recruitment is a successful approach to tissue donation, placing particular emphasis on clinical diagnosis through antemortem contact with donors, as well as stereological tissue sampling methods for neuroanatomical studies and frozen tissue sampling approaches that enable multiple assessments (e.g., RNA, DNA, protein, enzyme activity, binding) of the same tissue block. Promising scientific approaches for elucidating the molecular and cellular pathways in brain that may contribute to schizophrenia are briefly discussed. Despite different perspectives from three established brain collections, there is consensus that varied networking strategies, rigorous tissue and clinical characterization, sample and data accessibility, and overall adaptability are integral to the success of psychiatric brain banking.

KW - Brain banks

KW - brain collections

KW - postmortem human brain

KW - psychiatric

KW - psychosis

KW - schizophrenia

UR - http://www.scopus.com/inward/record.url?scp=78650487294&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78650487294&partnerID=8YFLogxK

U2 - 10.1016/j.biopsych.2010.05.025

DO - 10.1016/j.biopsych.2010.05.025

M3 - Review article

C2 - 20673875

AN - SCOPUS:78650487294

VL - 69

SP - 104

EP - 112

JO - Biological Psychiatry

JF - Biological Psychiatry

SN - 0006-3223

IS - 2

ER -